Ilaris (canakinumab) — Medica
cryopyrin-associated periodic syndromes (CAPS)
Preferred products
- Ilaris (canakinumab)
Initial criteria
- Patient meets the standard Prior Authorization Policy criteria for cryopyrin-associated periodic syndromes (CAPS) [documentation required]